Is it worth to buy PL Stock after their $138M loss? is there any hope?

Investor summaryNeutral

User questions if PacBio (PL) is a buy after reporting a $138M loss, seeking opinions on future prospects.

Bear points

Significant quarterly loss of $138M raises concerns about cash burn and financial sustainability.
Lack of provided fundamental analysis or growth catalysts makes the investment thesis weak.

This is a link post with no body text.View link ↗

Discussion · top comments

No comment snapshot fetched for this post yet.